For senior executives, investing in organic innovation often feels like a triumph of hope over experience. They’ve seen initiatives from their own organizations over-promise and under-deliver year after year. Frothy headlines about startups disrupting virtually every industry increase their sense of urgency as well as unease about their ability to respond. Pressure from hyperactive investors to deliver near-term results makes it harder and harder to dedicate operating expense to longer-term priorities like innovation.
